Neurosenz
Brand Name: Neurosenz
Generic Name: Norepinephrine (as bitartrate)
Active
Registration Number
DRP-15794
Dosage Form
Solution for IV Injection
Issuance Date
September 18, 2024
Expiry Date
September 18, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1 mg/mL (4 mg/ 4 mL)
PackagingUSP Type I Glass Ampoule x 4 mL (Box of 10's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Adrenergic and Dopaminergic Agent
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Norepinephrine (as bitartrate)Active
Monograph: norepinephrine (as bitartrate)